Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816159) titled 'MMA Infusion of Lidocaine for Treatment of Headache in Patients With Aneurysmal SAH' on Sept. 7.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Rigshospitalet, Denmark

Condition: Headaches Associated With Subarachnoid Hemorrhage (SAH)

Intervention: Drug: Lidocaine hydrochloride

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: December 2026

Target Sample Size: 90

To know more, visit https://cl...